Revenue: The sum of all revenue fields included for a company's operating activities.
Foghorn Therapeutics Inc. (FHTX) had Revenue of $3.27M for the most recently reported fiscal quarter, ending 2026-03-31.
| Income Statement Financials | |
|
Revenue |
$3.27M |
$-19.88M |
|
-- |
|
$3.27M |
|
$24.84M |
|
$-21.57M |
|
$1.70M |
|
$-19.88M |
|
$-19.88M |
|
$-19.88M |
|
$-19.88M |
|
$-19.88M |
|
$-19.88M |
|
$-21.57M |
|
$-21.72M |
|
69.54M |
|
69.54M |
|
$-0.29 |
|
$-0.29 |
|
| Balance Sheet Financials | |
$188.06M |
|
$1.71M |
|
$34.10M |
|
$222.17M |
|
$64.40M |
|
-- |
|
$234.17M |
|
$298.57M |
|
$-76.41M |
|
$-76.41M |
|
$-76.41M |
|
58.71M |
|
| Cash Flow Statement Financials | |
$-25.27M |
|
$-17.72M |
|
$49.77M |
|
$84.13M |
|
$90.91M |
|
$6.79M |
|
$2.38M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
2.92 |
|
-- |
|
-- |
|
-- |
|
-- |
|
100.00% |
|
-660.33% |
|
-660.33% |
|
-- |
|
-608.36% |
|
-608.36% |
|
$-25.27M |
|
-- |
|
-- |
|
-- |
|
0.01 |
|
-- |
|
-- |
|
-- |
|
26.01% |
|
26.01% |
|
-8.95% |
|
26.01% |
|
$-1.30 |
|
$-0.36 |
|
$-0.36 |
|